Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Avanir
Pharma
Eisai, GSK, Daiichi Sankyo—Fierce Pharma Asia
Eisia's lecanemab phase 3 had one patient death. China suspends GSK from volume-based procurement. Daiichi increases its Enhertu sales projection.
Angus Liu
Nov 4, 2022 9:00am
Astellas, Takeda, Lilly-Innovent and more—FiercePharmaAsia
Jan 17, 2020 8:40am
Otsuka's Avanir unit plots 140 layoffs after Nuedexta settlement
Jan 10, 2020 11:35am
Otsuka, China's bidding, Aurobindo and more—FiercePharmaAsia
Sep 27, 2019 10:10am
Avanir agrees to pay $116M over Nuedexta kickbacks probe
Sep 26, 2019 3:55pm
Feds put Acadia's Nuplazid marketing under the microscope
Mar 11, 2019 11:12am